Navigation Links
Rigel Announces Second Quarter 2013 Financial Results
Date:8/6/2013

rd-looking" statements, including, without limitation, statements related to the further development of certain drug candidates, including to the future plans with respect to fostamatanib and the timing of announcement of those plans and the results of certain studies, and the sufficiency of our funds and the timing of our cash.  Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "planned," "will," "expect," and similar expressions are intended to identify these forward-looking statements.  These forward-looking statements are based on Rigel's current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, the availability of resources to develop Rigel's product candidates and our need for additional capital in the future to sufficiently fund our operations and research, the uncertain timing of completion of and the success of clinical trials and the potential problems that may arise in the clinical development process, and that our corporate collaborations or license agreements may be unsuccessful, market competition, risks associated with and Rigel's dependence on Rigel's corporate partnerships, as well as other risks detailed from time to time in Rigel's reports filed with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the three months ended March 31, 2013. Rigel does not undertake any obligation to update forward-looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein.

 

Contact: Ryan D. Maynard
Phone: 650.624.1284'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rigel Announces First Quarter 2012 Financial Results
2. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
3. Rigel Announces Second Quarter 2012 Financial Results
4. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
5. Rigel to Present at UBS Global Life Sciences Conference
6. Rigel Announces Third Quarter 2012 Financial Results
7. Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
8. Rigel to Present at BIO CEO & Investor Conference
9. Rigel Announces Participation at Two Investor Conferences
10. Rigel Announces Fourth Quarter and Year End 2012 Financial Results
11. Rigel Announces First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... the sale to Galderma of all rights to Restylane, ... Valeant for $1.4 billion in cash, pursuant to the ... its acquisition of Galderma. "We are ... a company that is firmly committed to the aesthetic ...
(Date:7/10/2014)... -- Decision Resources Group finds that over half of ... Drug Administration,s (FDA) approval of Vifor Fresenius Medical Care ... by the FDA in November 2013 for the treatment ... dialysis. Other key findings from the report ... : , Bundling: Based ...
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... March 16, 2012 Obesity appears to significantly increase the ... rate of mortality even among those prescribed 18 or fewer ... emerged as a marker of increased vulnerability," said Robert ... Epidemiology and Prevention | Nutrition, Physical Activity and Metabolism 2012 ...
... 50th anniversary of Poison Prevention Week , March 18-24, ... pet owners that accidental poisonings are a common problem. ... in the home, and that,s true of pets as well.  ... household items are hazardous to pets.  The AVMA online ...
Cached Medicine Technology:Obesity Raises Death Risk Tied To Sleeping Pills 2Obesity Raises Death Risk Tied To Sleeping Pills 3Obesity Raises Death Risk Tied To Sleeping Pills 4Don't Give Your Pet a Deadly Dose; Medicines Top the List of Household Poisons for Pets 2
(Date:7/13/2014)... Recently, Fadhits.com, the distinguished wedding dress manufacturer ... promotion. According to the company’s senior spokesman, the ... All the company’s current and prospective customers can get ... end of July. , Fadhits.com is a well-known ... customers. The company has its own designers who can ...
(Date:7/13/2014)... 2014 Worldwide ladies are extremely responsive ... has taken a different approach and has created a ... offered in more colour choices that responded directly to ... of women’s special occasion apparels. The company’s pink bridesmaid ... are working hard to create the best products for ...
(Date:7/13/2014)... to get the best treatment and variations in the ... survival for blood cancer patients still varies widely between ... of survival in European adults to date, published in ... is that 5-year survival for most cancers of the ... likely reflecting the approval of new targeted drugs in ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Intraocular Lens ... and Forecast 2013 - 2019 , Intraocular lens (IOL) ... from myopia or cataracts. The lenses are inserted inside ... cataract surgery intraocular lens replaces the focusing power of ... original crystalline lens to deliver the light focusing function ...
(Date:7/13/2014)... Chromatography system is a physical method ... of biological samples such as air and water. ... two phase, namely mobile phase and stationary phase. ... the stationary phase, followed by the differential rate ... separation of mixture. Chromatography system plays an important ...
Breaking Medicine News(10 mins):Health News:Fashionable Pageant Dresses Now On Sale At Fadhits.com 2Health News:Angeldress.co.uk Announces Summer Sale For Pink And Red Bridesmaid Dresses; The Current Discount Is Up To 80% Off 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 2Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 3
... , , , ... With the return of busy school schedules combined ... back-to-basics when it comes to keeping on-the-go families fit and ... trainer, Valerie Waters, have teamed up to create simple solutions ...
... , NEW YORK, Sept. 2 The Prix Galien USA ... D. Sachs, Ph.D., of Columbia University with its 2009 Pro Bono Humanum ... the poorest corners of the globe. , , ... science and economics to global health problems in ways that have changed ...
... , ANN ARBOR, Mich., Sept. ... Commission Strategic Surveillance System (S3) scores through a quality improvement program ... , , Rush-Copley,s efforts were built upon an ... order entry (CPOE) system. , , Following an ...
... , , SAN BERNARDINO, ... stay healthy and well by once again offering seasonal flu ... 17 and run through November 1 at most Stater Bros. ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20030421/STATERLOGO ) , , ...
... , , , , ... Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI ), the leader in ... This latest agreement is a two-year extension of Humana,s original agreement ... expands the number of ZixCorp licenses bringing the total to 36,000. ...
... Cancer Center has received an $8 million grant from ... Institutes of Health (NCRR/NIH) to expand their laboratory animal ... advanced research into the fundamental biological processes underlying cancer, ... The funds for the grant were made available through ...
Cached Medicine News:Health News:Celebrity Fitness Trainer Valerie Waters Offers On-the-Go Families Back-to-Basics Tips 2Health News:Celebrity Fitness Trainer Valerie Waters Offers On-the-Go Families Back-to-Basics Tips 3Health News:Celebrity Fitness Trainer Valerie Waters Offers On-the-Go Families Back-to-Basics Tips 4Health News:Barry Bloom, Jeffrey Sachs to Be Honored for Introducing Modern Solutions to The World's Oldest Problems: Poverty And Disease 2Health News:Rush-Copley Medical Center Uses Thomson Reuters Order Sets Solution to Improve Joint Commission S3 Scores 2Health News:Rush-Copley Medical Center Uses Thomson Reuters Order Sets Solution to Improve Joint Commission S3 Scores 3Health News:Stater Bros. Helps Customers Fight the Flu 2Health News:Zix Corporation and Humana Renew and Expand Exclusive Agreement 2Health News:Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility 2
... Saturated Swabsticks are packaged ... foil-laminated pouches. Each 4 ... with precisely the correct ... package is terminally sterilized, ...
... alcohol and 10% povidone iodine formulated ... a barrier on the skin. The ... the povidone iodine, giving persistent protection ... catheter related infections for up to ...
... Aplicare's Saturated Swabsticks ... open, single-use foil-laminated pouches. ... is saturated with precisely ... solution. Each package is ...
... Aplicare's saturated swabsticks are packaged in easy ... inch swabstick is saturated with precisely the ... Gel Swabstick is saturated with a multi-purpose ... gel is also approved for venipuncture site ...
Medicine Products: